India & Cipla
7 shared events · Importance 3 · Last updated Jul 23, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
Ergen Dashboard
Domestic
India: India is experiencing a severe shortage of platinum-based cancer drugs, impacting its healthcare system and patients. The government's price caps on medicines are contributing to the supply crunch.
Cipla: Cipla>>> is one of the generic drugmakers in India>>> that produces platinum-based chemotherapy, and its production is affected by the platinum shortage and price caps.
Jun 09, 2026 · 9 articles
Business
India: Cipla's India business posted record quarterly sales of Rs 3,452 crore, growing 12%, with strong performance in chronic therapies.
Cipla: Cipla reported a 39% net profit decline due to North America sales drop and higher expenses; its India business achieved record sales. The company appointed a new CFO and expects sequential recovery in North America.
Jul 23, 2026 · 6 articles
Business
India: India is a key battleground for weight-loss drugs due to its large obesity population and is experiencing significant competition between Novo Nordisk and Eli Lilly and Company.
Cipla: Eli Lilly and Company has partnered with Cipla to market Tirzepatide in India, aiming to widen its distribution.
Nov 11, 2025 · 6 articles
Regulatory
India: India's regulatory framework is being tested; the case could clarify the applicability of drug laws to duty-free shops.
Cipla: Cipla is mentioned only as former employer of Murali Neelakantan; not directly involved.
Jul 07, 2026 · 17 articles
Business
Cipla: Cipla partnered with Eli Lilly and Company to market and distribute tirzepatide in India, similar to the Novo Nordisk-Emcure Pharmaceuticals collaboration.
Nov 10, 2025 · 6 articles
Business
Cipla: Cipla entered into an exclusive agreement with Pfizer India to market, distribute, and sell four of Pfizer's brands in India, expanding its presence in key therapy areas and leveraging its distribution capabilities.
Dec 19, 2025 · 6 articles
Regulatory
Cipla: Achin Gupta, MD & Global CEO of Cipla, delivered the vote of thanks at the India Pharma 2026 conference.
Apr 12, 2026 · 6 articles
ERGEN INTELLIGENCE
Explore this relationship live
Track how India and Cipla interact across events, view sentiment trends, and discover connected entities.
Open Dashboard